Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

Qingkun Liu,Emily M Johnson,Rachel K Lam,Qian Wang,Hong Bo Ye,Edward N Wilson,Paras S Minhas,Ling Liu,Michelle S Swarovski,Stephanie Tran,Jing Wang,Swapnil S Mehta,Xi Yang,Joshua D Rabinowitz,Samuel S Yang,Mehrdad Shamloo,Christoph Mueller,Michelle L James,Katrin I Andreasson

DOI: https://doi.org/10.1038/s41590-019-0421-2

Abstract:Stroke is a multiphasic process in which initial cerebral ischemia is followed by secondary injury from immune responses to ischemic brain components. Here we demonstrate that peripheral CD11b+CD45+ myeloid cells magnify stroke injury via activation of triggering receptor expressed on myeloid cells 1 (TREM1), an amplifier of proinflammatory innate immune responses. TREM1 was induced within hours after stroke peripherally in CD11b+CD45+ cells trafficking to ischemic brain. TREM1 inhibition genetically or pharmacologically improved outcome via protective antioxidant and anti-inflammatory mechanisms. Positron electron tomography imaging using radiolabeled antibody recognizing TREM1 revealed elevated TREM1 expression in spleen and, unexpectedly, in intestine. In the lamina propria, noradrenergic-dependent increases in gut permeability induced TREM1 on inflammatory Ly6C+MHCII+ macrophages, further increasing epithelial permeability and facilitating bacterial translocation across the gut barrier. Thus, following stroke, peripheral TREM1 induction amplifies proinflammatory responses to both brain-derived and intestinal-derived immunogenic components. Critically, targeting this specific innate immune pathway reduces cerebral injury.